Gumimba, Earl Ian B.

HRN: 23-64-97  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2023
CEFTRIAXONE 1G (VIAL)
09/03/2023
09/10/2023
IV
2gm
OD
Infected Wound
Waiting Final Action 
09/03/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/03/2023
09/10/2023
IV
600mg
Q6
Infected Wound
Waiting Final Action 
09/03/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/03/2023
09/09/2023
IV
4.5g
Q6
Sepsis Secondary To Infected Sacral Ulcer
Waiting Final Action 
09/03/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
09/03/2023
09/09/2023
TOPICAL
1%
BID
Scald Burn
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: